switching from tirzepatide to zepbound Zepbound® (Tirzepatide) Prescribed Online with Ongoing Care Switch from Ozempic to Zepbound:

Dihexa remains an investigational compound and is not FDA-approved for medical use

When the preliminary results were announced in April, it was accompanied by this cover of TIME magazine and this article

As a result, many women experience: Acne or breakouts Melasma (dark patches on the face) Dry, itchy, or sensitive skin Stretch marks Darkening of nipples, underarms, and inner thighs These changes are normal and usually temporary, but proper care can help manage them safely

However, it is concerning that AKI events associated with GLP-1 agonists may have serious adverse outcomes, including in some cases the need for hemodialysis

Both drugs activate the same GLP-1 and GIP receptors, so combining them would create overlapping and potentially dangerous receptor overstimulation